The Patent Finder

Savara Inc.

Also on record
Records under this name other than patents Savara Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Savara Inc.

PatentTitleStatus Expires Confidence
US 9,757,411Poloxamer therapy for heart failure
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,403,941Poloxamer Composition Free of Long Circulating Material and Methods for Production and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,501,577Poloxamer Composition Free of Long Circulating Material and Methods for Production and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,155,679Poloxamer Composition Free of Long Circulating Material and Methods for Production and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,572,774Dry Powder Vancomycin Compositions and Associated Methods
Lapsed on the fee record
Ended Feb 21, 2025 · Low confidence
Lapsed on the fee recordEnded Feb 21, 2025Low confidence
US 9,526,695Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,526,696Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,526,697Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,526,698Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,486,462Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
Lapsed on the fee record
Ended Nov 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2024From the USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited